Clinical trials
Terminated Phase 1 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
184 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 9 |
| 2018 | 5 |
| 2019 | 16 |
| 2020 | 23 |
| 2021 | 29 |
| 2022 | 37 |
| 2023 | 27 |
| 2024 | 15 |
| 2025 | 9 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 184 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jiangsu HengRui Medicine Co., Ltd. | 9 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 8 |
| Institute of Hematology & Blood Diseases Hospital, China | 7 |
| Innovent Biologics (Suzhou) Co. Ltd. | 6 |
| BeOne Medicines | 5 |
| BioRay Pharmaceutical Co., Ltd. | 5 |
| Shanghai Junshi Bioscience Co., Ltd. | 5 |
| BeiGene | 4 |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 4 |
| Grit Biotechnology | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 11 |
| Recurrence | 10 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Lymphoma, Non-Hodgkin | 8 |
| Pancreatic Neoplasms | 6 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Breast Neoplasms | 4 |
| Lymphoma, B-Cell | 4 |
| Neoplasm Metastasis | 4 |
| Colorectal Neoplasms | 3 |
Trials
Showing 1 to 25 of 184. Each trial links to its page on Pharma Observatory.
84 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.